Skip to main content
. 2016 Jan 18;6:19534. doi: 10.1038/srep19534

Figure 5. Sulindac decreased tumor vasculature in tumor microenvironment.

Figure 5

(A) CD31 staining revealed that sulindac reduced tumor angiogenesis in 4T1 tumor model. Scale bars, 50 μm. (B) Quantification of tumor vessel densities was assessed. *P < 0.05. (C) The level of VEGF and PlGF was evaluated by RT-PCR. Sulindac reduced pro-angiogenic factors VEGF and PlGF. **P < 0.01.